Key result
Sex differences in arterial pressure and flow waveforms may contribute to CVD disparities.
Why the study?
Sex differences in arterial pressure and flow waveform physiology may contribute to disparities in CVD presentation and outcomes, but remain understudied.
This review highlights the importance of sex differences in arterial pressure and flow waveform physiology across the life course as potential explanatory factors for disparities in cardiovascular disease presentation and outcomes.
May guide sex-specific hemodynamic risk assessment in women; leaves open prospective validation of waveform-targeted interventions.
Cardiovascular disease (CVD) has long been deemed a disease of old men. However, in 2019 CVD accounted for 35% of all deaths in women and, therefore, remains the leading cause of death in both men and women. There is increasing evidence to show that risk factors, pathophysiology and health outcomes related to CVD differ in women compared with men, yet CVD in women remains understudied, underdiagnosed and undertreated. Differences exist between the sexes in relation to the structure of the heart and vasculature, which translate into differences in blood pressure and flow waveform physiology. These physiological differences between women and men may represent an important explanatory factor contributing to the sex disparity in CVD presentation and outcomes but remain understudied. In this review we aim to describe sex differences in arterial pressure and flow waveform physiology and explore how they may contribute to differences in CVD in women compared to men. Given that unfavourable alterations in the cardiovascular structure and function can start as early as in utero, we report sex differences in waveform physiology across the entire life course.
No takes yet. Share an insight, caveat, or question.
Picone et al. (2022) conducted a review in Cardiovascular disease. Sex differences in arterial pressure and flow waveform physiology across the life course may contribute to disparities in cardiovascular disease, which accounted for 35% of all deaths in women in 2019.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: